The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CVS Health Corporation ( CVS ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Larry McGrath - Executive VP, Chief Strategy Officer & Chief Strategic Advisor to the CEO J. Joyner - President, CEO & Director Brian Newman - Executive VP & CFO Prem Shah - Executive VP & Group President Steven Nelson - Executive VP & President of Aetna Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Justin Lake - Wolfe Research, LLC Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Michael Cherny - Leerink Partners LLC, Research Division Eric Percher - Nephron Research LLC Andrew Mok - Barclays Bank PLC, Research Division George Hill - Deutsche Bank AG, Research Division Kevin Caliendo - UBS Investment Bank, Research Division Presentation Operator Hello, and welcome to CVS Health's Third Quarter 2025 Earnings Call.
CVS reported Q3 financials showing it beat on earnings and revenue, which resulted in strong forward guidance.
CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
CVS Health (CVS) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.09 per share a year ago.
CVS Health's stock falls as a large charge to write off the value of an underperforming business takes the shine off an otherwise strong earnings report.
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy MinuteClinics.
CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. The quarterly results cap David Joyner's first full year as CEO of the company, which struggled to drive higher profits and improve its stock performance under Karen Lynch.
CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.
CVS Health is shuttering 16 Oak Street Health Centers, or 7% of the total number of the senior-focused primary care locations the company operates across the U.S.